The compound is not a therapeutic substance, food product or cosmetic material and cannot be repurposed or relabeled for such use
Some of its individual ingredients have been studied for their potential role in appetite control or metabolism
The long half-life creates a buffering effect that prevents dramatic swings in medication levels
GLP-1 receptor agonists available in the UK include: Semaglutide (Ozempic, Wegovy, Rybelsus) Dulaglutide (Trulicity) Liraglutide (Victoza, Saxenda) Exenatide (Byetta, Bydureon) These medications are administered either as subcutaneous injections (weekly or daily, depending on the formulation) or as oral tablets (Rybelsus)
While the overall risk of NAION remains low, the increased relative risk provides a strong basis for claims when the injury is well documented
In a clinic, your peptides come through a regulated pharmacy, your provider confirms the right candidate and dose, and your response is monitored